Purpose: In the last years, it has emerged the unmet need for imaging technologies able to accurately describe the biological and clinical heterogeneity of glioma, assess responsiveness to therapy, and predict patient outcomes. The increasing number of additional imaging parameters primarily derived from advanced Magnetic Resonance Imaging...
-
2021 (v1)PublicationUploaded on: February 7, 2024
-
2019 (v1)Publication
Mantle cell lymphoma (MCL) is an aggressive lymphoma subtype with poor prognosis in which 18F-FDG-PET/CT role in treatment response evaluation and prediction of outcome is still unclear. The aim of this multicentric study was to investigate the role of 18F-FDG-PET/CT in staging MCL and the prognostic role of Deauville criteria (DC) in terms of...
Uploaded on: May 13, 2023 -
2023 (v1)Publication
Aim: To assess the role of baseline 18F-fluorodeoxyglucose ([18F]FDG)-positron emission tomography/computed tomography (PET/CT) in predicting response to immunotherapy after 6 months and overall survival (OS) in patients with lung cancer (LC) or malignant melanoma (MM). Materials and Methods: Data from a multicenter, retrospective study...
Uploaded on: February 14, 2024 -
2023 (v1)Publication
AIM: To examine the role of [18F]FDG PET/CT for assessing response to immunotherapy in patients with some solid tumors. METHODS: Data recorded in a multicenter (n = 17), retrospective database between March and November 2021 were analyzed. The sample included patients with a confirmed diagnosis of a solid tumor who underwent serial [18F]FDG...
Uploaded on: February 14, 2024